Hematopoietic stem cell engineering at a crossroads Journal Article
| Authors: | Riviere, I.; Dunbar, C. E.; Sadelain, M. |
| Article Title: | Hematopoietic stem cell engineering at a crossroads |
| Abstract: | The genetic engineering of hematopoietic stem cells is the basis for potentially treating a large array of hereditary and acquired diseases, and stands as the paradigm for stem cell engineering in general. Recent clinical reports support the formidable promise of this approach but also highlight the limitations of the technologies used to date, which have on occasion resulted in clonal expansion, myelodysplasia, or leukemogenesis. New research directions, predicated on improved vector designs, targeted gene delivery or the therapeutic use of pluripotent stem cells, herald the advent of safer and more effective hematopoietic stem cell therapies that may transform medical practice. In this review, we place these recent advances in perspective, emphasizing the solutions emerging from a wave of new technologies and highlighting the challenges that lie ahead. |
| Keywords: | review; myelodysplastic syndrome; genetic engineering; clonal variation; leukemogenesis; safety; pluripotent stem cell; hematopoietic stem cell; technology; gene delivery system; cell engineering |
| Journal Title: | Blood |
| Volume: | 119 |
| Issue: | 5 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-02-02 |
| Start Page: | 1107 |
| End Page: | 1116 |
| Language: | English |
| DOI: | 10.1182/blood-2011-09-349993 |
| PROVIDER: | scopus |
| PUBMED: | 22096239 |
| PMCID: | PMC3277348 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 March 2012" - "CODEN: BLOOA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work